Reports Q4 revenue $502M, consensus $486.22M. “Our strong fourth quarter results reflect continued top-line outperformance versus our expectations, the completion of our portfolio restructuring, and the related overhead expense reductions,” said Mark S. Ordan, Chief Executive Officer of Pediatrix Medical (MD) Group. “I am honored and excited to reassume the role of Chief Executive Officer, and I am committed to furthering the Company’s strategic focus on supporting clinical excellence, strengthening our hospital and health system relationships, and optimizing our operating efficiency. We believe this focus, supported by our financial strength, will benefit all of our stakeholders.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MD:
- Is MD a Buy, Before Earnings?
- Cautious Hold on Pediatrix Medical Group Amidst Birth Rate Growth and Leadership Changes
- Pediatrix Medical Group Appoints New CEO Mark S. Ordan
- Pediatrix Medical Group Appoints New CEO Amidst Strategy Shift
- Pediatrix Medical says Mark Ordan to return as CEO, effective immediately
Questions or Comments about the article? Write to editor@tipranks.com